Topic

Multiple Sclerosis Treatment History

Multiple Sclerosis Treatment History Events

1868 Jean-Martin Charcot Diagnoses Multiple Sclerosis
The French neurologist Jean-Martin Charcot (1825–1893) was the first person to recognize multiple sclerosis as a distinct disease in 1868. Summarizing previous reports and adding his own ...
1955 The Disease Sclerose En Plagues's Name is Changed to Multiple Sclerosis
It was called sclerose en plagues until 1955 when the name was changed to Multiple Sclerosis.
1959 May 18 FDA Approves Pharmacia and UpJohn's Solu-Medrol Solution
Treating certain conditions associated with decreased adrenal gland function. It is also used to treat severe inflammation caused by certain conditions, including severe asthma, severe al...
1993 Jul 23 FDA Approves Bayer HealthCare's Betaseron to Treat Relapsing Forms of Multiple Sclearosis
BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and is shown to delay the progression to clinicall...
1995 Avonex Comes Out as a Drug to Treat Multiple Sclerosis
Avonex has been available since 1995. It is made by Biogen Idec. Avonex comes in new, prefilled syringes (called luer lock), which can be left unrefrigerated for up to 7 days. However, A...
1996 Dec 20 FDA Approves Teva's Copaxone to Reduce Frequency in Patients with Relapsing-Remitting Multiple Sclerosis
Copaxone is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients who have experienced a first clinical e...
1998 Dec 24 FDA Approves Cephalon's Provigil
So I mentioned this to my neurologist who gave me some samples of a medication to try. Those samples were for Provigil, a prescription medication used to improve wakefulness in adults wh...
2000 Oct FDA Approves Immunex's Novantrone to Reduce Disability and the Number of Relapses in Patients with Multiple Sclerosis
Novantrone has been approved for use in reducing neurologic disability and/or the frequency of relapses in patients with secondary (chronic) progressive, progressive relapsing, or worseni...
2002 Mar 8 FDA Approves Pfitzer's Rebif for the Treatment of Relapsing Forms of Multiple Sclerosis
This March, the U.S. Food and Drug Administration (FDA) approved Rebif, a form of interferon beta-1a manufactured by Serono, for treatment of relapsing forms of MS. With the addition of R...
2004 Nov 23 FDA Approves Biogen's Tysabri
Tysabri is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help t...
2010 Jan 22 FDA Approves Acorda's Ampyra
Ampyra, formerly known as fampridine SR, is a tablet containing a sustained-release formula of 4-aminopyridine, which blocks tiny pores, or potassium channels, on the surface of nerve fib...